# Treatment of PED With AMT and Autologous Serum

> **NCT00238862** · NA · COMPLETED · sponsor: **King Khaled Eye Specialist Hospital** · enrollment: 180 (—)

## Conditions studied

- Corneal Epithelial Defect

## Interventions

- **PROCEDURE:** Amniotic membrane transplantation
- **DRUG:** Autologous serum/BSS 20%

## Key facts

- **NCT ID:** NCT00238862
- **Lead sponsor:** King Khaled Eye Specialist Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 180 (—)
- **Last updated:** 2021-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00238862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00238862, "Treatment of PED With AMT and Autologous Serum". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00238862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*